About Us
Our People
Board of Directors
Our Product
In Development
Mission
Investors
Careers
Contact
Contact Us
Media Contact
Investor Contact
Investors
Investors Home
Stock Quote
Stock Information
Historical Stock Price
News Releases
Events and Presentations
SEC Filings
Analyst Coverage
Corporate Governance
Board of Directors
Charters & Code of Ethics
FAQs
Investor Contacts & Alerts
Investors Home
Stock Quote
News Releases
Events and Presentations
SEC Filings
Analyst Coverage
Corporate Governance
FAQs
Investor Contacts & Alerts
News Releases
Year
All Years
2021
2020
2019
2018
2017
2016
2015
2014
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Dec 3, 2020
The U.S. Department of Veterans Affairs Awards Contract to Evofem Biosciences for Phexxi®
Nov 20, 2020
Evofem Biosciences to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 12, 2020
Evofem Biosciences to Present at Stifel Virtual Healthcare Conference
Nov 9, 2020
Evofem Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Launched Phexxi™ (lactic acid, citric acid, potassium bitartrate) in U.S. for Hormone-free Contraception
Photos
1
Oct 27, 2020
Evofem Biosciences to Report Third Quarter 2020 Results and Provide Corporate Update on Monday, November 9, 2020
-- Conference Call Scheduled for 5:00 p.m. ET --
Show
5
10
25
50
100
per page
«
1
2
3
4
5
6
7
8
9
…
25
»